You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDV3100

Showing 26 - 50 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Prostate Cancer Trial in United States (Everolimus, Enzalutamide)

Completed
  • Prostate Cancer
  • Fort Myers, Florida
  • +4 more
May 3, 2021

Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

Active, not recruiting
Has Results
  • Progressive Metastatic Prostate Cancer
  • Beijing, China
  • +46 more
Jan 13, 2023

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Drug Resistance in Metastatic Castration-Resistant Prostate

Completed
  • Castration Levels of Testosterone
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
  • +2 more
Sep 24, 2020

Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • San Francisco, California
  • +21 more
Aug 18, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Cerebrovascular Circulation Trial in London (Darolutamide (BAY1841788), Enzalutamide, Placebo)

Completed
  • Cerebrovascular Circulation
  • Darolutamide (BAY1841788)
  • +2 more
  • London, United Kingdom
    Centre for Neuroimaging Sciences, King's College
Oct 28, 2020

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Completed
  • Castration-resistant Prostate Cancer
  • Aichi, Japan
  • +46 more
Dec 22, 2020

Advanced Hepatocellular Carcinoma Trial in Worldwide (Enzalutamide, Placebo)

Completed
Has Results
  • Advanced Hepatocellular Carcinoma
  • San Francisco, California
  • +37 more
Feb 18, 2022

Prostate Cancer, Hormone Refractory Prostate Cancer Trial in United States (MDV3100)

Completed
Has Results
  • Prostate Cancer
  • Hormone Refractory Prostate Cancer
  • MDV3100
  • Boston, Massachusetts
  • +8 more
Sep 10, 2019

Prostate Cancer Trial in Japan (Enzalutamide, Flutamide, Androgen deprivation therapy)

Completed
Has Results
  • Prostate Cancer
  • Nagoya, Aichi, Japan
  • +46 more
May 18, 2021

Prostate Carcinoma Metastatic to the Bone, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide)

Completed
Has Results
  • Prostate Carcinoma Metastatic to the Bone
  • Castration Resistant Prostate Cancer
  • Detroit, Michigan
  • +4 more
Apr 20, 2020

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Enzalutamide)

Completed
Has Results
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 19, 2019

Prostate Cancer Trial in New York, Norfolk (MDV3100)

Completed
Has Results
  • Prostate Cancer
  • MDV3100
  • New York, New York
  • +2 more
Jan 25, 2019

Prostate Cancer Trial in Canada, United States (Enzalutamide, Active Surveillance)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +53 more
Oct 14, 2021

Prostate Cancer Trial in Worldwide (enzalutamide, abiraterone acetate, prednisone)

Recruiting
  • Prostate Cancer
  • Anchorage, Alaska
  • +126 more
Aug 23, 2022

Length in mCRPC Patients Treated With Enzalutamide in Sweden

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Malmo, Sweden
    Site SE46001
Aug 15, 2019

Breast Cancer Trial in United States (enzalutamide, anastrozole, exemestane)

Completed
Has Results
  • Breast Cancer
  • Aurora, Colorado
  • +16 more
May 7, 2019

Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +91 more
Jan 18, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in Houston (enzalutamide, abiraterone acetate, prednisone)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • Houston, Texas
    Site US2492 MD Anderson Cancer Ctr
Jan 16, 2019

Bladder Cancer, Carcinoma, Transitional Cell, Renal Pelvis Cancer Trial in Tampa, Minneapolis (Enzalutamide, Cisplatin,

Completed
Has Results
  • Bladder Cancer
  • +4 more
  • Tampa, Florida
  • +1 more
Jun 7, 2019

Adenocarcinoma of the Prostate Trial in United States (Enzalutamide, SRT)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Washington, District of Columbia
  • +8 more
Feb 3, 2022

Prostate Cancer, Prostate Tumors, Castration Resistant Prostate Cancer (CRPC) Trial in Japan (MDV3100)

Completed
  • Prostate Cancer
  • +2 more
  • MDV3100
  • Chubu, Japan
  • +6 more
Nov 9, 2018

Adenocarcinoma of the Prostate Trial in Cleveland (enzalutamide)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 11, 2019